RNF24

gene
On this page

Also known as G1L

Summary

RNF24 (ring finger protein 24, HGNC:13779) is a protein-coding gene on chromosome 20p13, encoding RING finger protein 24 (Q9Y225). May play a role in TRPCs intracellular trafficking.

This gene encodes an integral membrane protein that contains a RING-type zinc finger. The encoded protein may interact with multiple transient receptor potential cation channel subfamily C (TRPC) proteins and regulate the trafficking and insertion of these proteins into the plasma membrane.

Source: NCBI Gene 11237 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 19 total
  • MANE Select transcript: NM_001134337

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13779
Approved symbolRNF24
Namering finger protein 24
Location20p13
Locus typegene with protein product
StatusApproved
AliasesG1L
Ensembl geneENSG00000101236
Ensembl biotypeprotein_coding
OMIM612489
Entrez11237

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 7 protein_coding

ENST00000336095, ENST00000358395, ENST00000432261, ENST00000545616, ENST00000905730, ENST00000905731, ENST00000905732

RefSeq mRNA: 4 — MANE Select: NM_001134337 NM_001134337, NM_001134338, NM_001321749, NM_007219

CCDS: CCDS13074, CCDS46577

Canonical transcript exons

ENST00000358395 — 6 exons

ExonStartEnd
ENSE0000065793739349943935073
ENSE0000065793839451773945218
ENSE0000085889139273113934201
ENSE0000110866139482373948279
ENSE0000153900340154374015558
ENSE0000366175439638753964024

Expression profiles

Bgee: expression breadth ubiquitous, 257 present calls, max score 95.84.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.2090 / max 948.6384, expressed in 1813 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
18617923.87031813
1861780.3387143

Top tissues by expression

293 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065595.84gold quality
bloodUBERON:000017894.71gold quality
pericardiumUBERON:000240794.54gold quality
cartilage tissueUBERON:000241893.31gold quality
nippleUBERON:000203092.58gold quality
oocyteCL:000002392.55gold quality
renal medullaUBERON:000036290.91gold quality
stromal cell of endometriumCL:000225590.44gold quality
trigeminal ganglionUBERON:000167588.32gold quality
endothelial cellCL:000011588.08silver quality
descending thoracic aortaUBERON:000234587.90gold quality
cortical plateUBERON:000534387.46gold quality
dorsal root ganglionUBERON:000004487.42gold quality
monocyteCL:000057687.16gold quality
corpus epididymisUBERON:000435987.08gold quality
mononuclear cellCL:000084287.02gold quality
leukocyteCL:000073887.01gold quality
bone marrowUBERON:000237186.77gold quality
ganglionic eminenceUBERON:000402386.36gold quality
thoracic aortaUBERON:000151586.34gold quality
ascending aortaUBERON:000149686.27gold quality
trabecular bone tissueUBERON:000248385.47gold quality
dorsal motor nucleus of vagus nerveUBERON:000287085.28gold quality
parotid glandUBERON:000183185.25gold quality
parietal lobeUBERON:000187284.73gold quality
synovial jointUBERON:000221784.69gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.47gold quality
embryoUBERON:000092284.46gold quality
bone marrow cellCL:000209284.41gold quality
inferior vagus X ganglionUBERON:000536384.40gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

282 targeting RNF24, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4533100.0069.482758
HSA-MIR-9-5P100.0072.282361
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-4425100.0067.591049
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-12118100.0065.881270
HSA-MIR-428299.9975.366408
HSA-MIR-366299.9973.825684
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-453499.9966.581907
HSA-MIR-548AW99.9972.573559
HSA-MIR-548P99.9872.253784
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372

Literature-anchored findings (GeneRIF, showing 1)

  • Results indicate that RNF24 interacts with TRPC cation channels in the Golgi apparatus and affects TRPC intracellular trafficking without affecting their activity. (PMID:17850865)

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
danio_reriornf24ENSDARG00000036965
mus_musculusRnf24ENSMUSG00000048911
rattus_norvegicusRnf24ENSRNOG00000088070
caenorhabditis_elegansWBGENE00015641
caenorhabditis_elegansWBGENE00015642
caenorhabditis_elegansWBGENE00015818
caenorhabditis_elegansWBGENE00017589
caenorhabditis_elegansWBGENE00020665
caenorhabditis_elegansWBGENE00022262
caenorhabditis_elegansWBGENE00022265

Paralogs (1): RNF122 (ENSG00000133874)

Protein

Protein identifiers

RING finger protein 24Q9Y225 (reviewed: Q9Y225)

All UniProt accessions (1): Q9Y225

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in TRPCs intracellular trafficking.

Subunit / interactions. Interacts with TRPC1, TRPC3, TRPC4, TRPC5, TRPC6 and TRPC7.

Subcellular location. Golgi apparatus membrane.

Isoforms (2)

UniProt IDNamesCanonical?
Q9Y225-11yes
Q9Y225-22

RefSeq proteins (4): NP_001127809, NP_001127810, NP_001308678, NP_009150 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001841Znf_RINGDomain
IPR011016Znf_RING-CHDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR048025RNF24_RING-H2Domain
IPR050731HRD1_E3_ubiq-ligasesFamily

Pfam: PF13639

UniProt features (12 total): strand 4, turn 2, chain 1, transmembrane region 1, helix 1, zinc finger region 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2EP4SOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y225-F170.820.14

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 197 (showing top): TGCGCANK_UNKNOWN, ENK_UV_RESPONSE_KERATINOCYTE_UP, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, MORF_RAD51L3, SP1_Q2_01, MAHAJAN_RESPONSE_TO_IL1A_DN, MORF_CTSB, BLALOCK_ALZHEIMERS_DISEASE_UP, MORF_IL4, RIGGI_EWING_SARCOMA_PROGENITOR_DN, MORF_PRKCA, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN, SCHLOSSER_SERUM_RESPONSE_DN, BENPORATH_NOS_TARGETS, CAAGGAT_MIR362

GO Biological Process (0):

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): Golgi membrane (GO:0000139), Golgi apparatus (GO:0005794), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transition metal ion binding1
binding1
cation binding1
Golgi apparatus1
bounding membrane of organelle1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

784 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RNF24TRPC6Q9Y210855
RNF24TRPC4Q9UBN4691
RNF24TRPC5Q9UL62688
RNF24TRPM2O94759650
RNF24TRPC3Q13507637
RNF24TRPC1P48995605
RNF24PANK2Q9BZ23585
RNF24PCED1AQ9H1Q7498
RNF24RWDD1Q9H446492
RNF24UBOX5O94941475
RNF24CLRN3Q8NCR9474
RNF24KCTD9Q7L273463
RNF24ANK2Q01484457
RNF24ANK3Q12955455
RNF24ANK1P16157454

IntAct

4 interactions, top by confidence:

ABTypeScore
UQCRHRNF24psi-mi:“MI:0915”(physical association)0.560
RNF24UQCRHpsi-mi:“MI:0915”(physical association)0.560
MFSD14AFAM171A2psi-mi:“MI:0914”(association)0.350

BioGRID (22): RNF24 (Two-hybrid), RNF24 (PCA), RNF24 (Two-hybrid), RNF24 (Two-hybrid), ARMC1 (Two-hybrid), NKG7 (Two-hybrid), TIMMDC1 (Two-hybrid), PLP1 (Two-hybrid), NT5E (Two-hybrid), VAMP1 (Two-hybrid), SLC10A6 (Two-hybrid), HIATL1 (Two-hybrid), NRSN1 (Two-hybrid), GOLT1A (Two-hybrid), BNIP3 (Two-hybrid)

ESM2 similar proteins: A0PJ23, A9JR22, A9JR44, B0BLK0, B0BLK7, B0BLK9, B2C4J2, B2MW50, B2ZDY1, E0VIU9, G1TZ76, J7H5K9, O43034, O64650, O73557, P03128, P11302, P11331, P18541, P19325, P19326, P36113, P42677, P47904, Q06651, Q06834, Q197D3, Q27YE2, Q27YE6, Q2KHT7, Q6IUF9, Q6IVU5, Q6R7D2, Q6R7D3, Q6RSS3, Q6UY71, Q6ZWU9, Q71TY3, Q7JUR5, Q7PN68

Diamond homologs: O13959, P62877, P62878, Q08273, Q20052, Q23457, Q3ZCF6, Q54K33, Q54L48, Q5R8A2, Q5UQ40, Q7X843, Q8BGI1, Q8QG64, Q940X7, Q9CPX9, Q9M2B0, Q9M9L0, Q9NHX0, Q9NYG5, Q9UBF6, Q9W5E1, Q9WTZ1, Q9Y225, A5WWA0, E9QAU8, F4HZZ4, F4HZZ5, O22197, O43567, O54965, O64763, P0C035, P0CH30, P0DPR2, P87119, Q06003, Q07G42, Q08CG8, Q08D68

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RNF24ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

19 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance13
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1628 predictions. Top by Δscore:

VariantEffectΔscore
20:3934992:A:ACdonor_gain1.0000
20:3934993:C:CAdonor_gain1.0000
20:3934993:CTTT:Cdonor_gain1.0000
20:3935069:CAGAG:Cacceptor_gain1.0000
20:3935074:C:CCacceptor_gain1.0000
20:3945171:ACTTA:Adonor_loss1.0000
20:3945173:TTACC:Tdonor_loss1.0000
20:3945174:TA:Tdonor_loss1.0000
20:3945175:A:AGdonor_loss1.0000
20:3945176:C:Gdonor_loss1.0000
20:3945217:ACCTG:Adonor_loss1.0000
20:3964025:C:CCacceptor_gain1.0000
20:3934120:A:ACdonor_gain0.9900
20:3934121:C:CCdonor_gain0.9900
20:3934985:AATAC:Adonor_loss0.9900
20:3934986:ATAC:Adonor_loss0.9900
20:3934990:T:TGdonor_loss0.9900
20:3934991:TACTT:Tdonor_loss0.9900
20:3934993:C:Tdonor_loss0.9900
20:3935071:GAG:Gacceptor_gain0.9900
20:3935073:GC:Gacceptor_loss0.9900
20:3935074:C:CAacceptor_loss0.9900
20:3945215:TAACC:Tdonor_loss0.9900
20:3945216:AACCT:Aacceptor_loss0.9900
20:3945217:ACCT:Aacceptor_loss0.9900
20:3945218:CCTG:Cacceptor_loss0.9900
20:3945219:CTGTA:Cdonor_loss0.9900
20:3945220:T:TCacceptor_loss0.9900
20:3945220:TGTAA:Tdonor_loss0.9900
20:3945221:G:Cacceptor_loss0.9900

AlphaMissense

983 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:3934156:G:CC118W1.000
20:3934157:C:AC118F1.000
20:3934157:C:GC118S1.000
20:3934157:C:TC118Y1.000
20:3934158:A:GC118R1.000
20:3934158:A:TC118S1.000
20:3934163:G:TP116H1.000
20:3934164:G:AP116S1.000
20:3934165:A:CC115W1.000
20:3934166:C:GC115S1.000
20:3934166:C:TC115Y1.000
20:3934167:A:GC115R1.000
20:3934167:A:TC115S1.000
20:3934184:A:GL109P1.000
20:3934186:C:AW108C1.000
20:3934186:C:GW108C1.000
20:3934187:C:GW108S1.000
20:3934188:A:GW108R1.000
20:3934188:A:TW108R1.000
20:3934196:A:GL105P1.000
20:3934196:A:TL105H1.000
20:3934198:G:CC104W1.000
20:3934199:C:GC104S1.000
20:3934200:A:GC104R1.000
20:3934200:A:TC104S1.000
20:3935001:G:CH101D1.000
20:3935002:G:CF100L1.000
20:3935002:G:TF100L1.000
20:3935003:A:CF100C1.000
20:3935003:A:GF100S1.000

dbSNP variants (sampled 300 via entrez): RS1000013313 (20:3997118 C>A,T), RS1000026891 (20:3945959 T>A), RS1000072371 (20:3989566 T>C), RS1000083616 (20:4001985 G>T), RS1000102545 (20:3942088 A>G), RS1000145218 (20:3927106 G>A), RS1000163399 (20:3964341 A>T), RS1000175950 (20:4008957 A>C), RS1000208689 (20:3969901 G>A), RS1000240591 (20:3960204 G>A), RS1000287047 (20:4015298 G>T), RS1000293108 (20:3960621 T>C), RS1000329289 (20:4015567 G>A), RS1000340368 (20:4015001 C>T), RS1000381913 (20:4015509 G>A,C)

Disease associations

OMIM: gene MIM:612489 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST003803_5Response to antidepressants in depression2.000000e-06
GCST004114_1Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)6.000000e-07
GCST008839_433Height1.000000e-16
GCST010320_116PR interval2.000000e-15
GCST010321_92PR interval7.000000e-16
GCST010796_4419Electrocardiogram morphology (amplitude at temporal datapoints)2.000000e-08
GCST010796_4420Electrocardiogram morphology (amplitude at temporal datapoints)4.000000e-08
GCST011742_38Triglyceride levels in HIV infection9.000000e-06

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004462PR interval
EFO:0004327electrocardiography
EFO:0004530triglyceride measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

52 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, increases expression4
bisphenol Adecreases methylation, increases expression2
Air Pollutantsaffects expression, increases abundance, increases expression2
Formaldehydeincreases expression2
bisphenol Faffects cotreatment, decreases expression1
methylmercuric chlorideincreases expression1
triphenyl phosphateaffects expression1
beta-lapachoneincreases expression1
sodium arseniteincreases expression1
benzo(e)pyreneincreases methylation1
nickel sulfatedecreases expression1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
CGP 52608affects binding, increases reaction1
oxamflatinincreases expression1
apicidinincreases expression1
K 7174increases expression1
scriptaidincreases expression1
bisphenol Sincreases methylation1
Sunitinibincreases expression1
Arsenic Trioxideincreases expression1
Panobinostatincreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneincreases expression1
Cisplatindecreases expression1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Deoxyglucosedecreases expression1
Dexamethasoneaffects cotreatment, decreases expression1
Diurondecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): drug-induced liver injury